IDH1R132H mutation was statistically related to WHO grade in primary tumors, 85.7% of IDH1 mutated tumors were classified as grade II (p < .001) (Table 3), being R132H mutation, significantly more frequent in low grades of primary brain tumors (p = .042) (data not shown). The gene discussed is IDH1; the disease is brain neoplasm.